Anew Labs
An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
$290MFunding
LeadIC
IDG Capital
Activity from announced rounds
Activity in this selectionOct 6, 2026 · AI · Sep 7, 2026
IDG Capital is the investment firm identified in InfiMaker records and as an angel-round co-lead by Apex Intelligence.
Recorded funding activity
Apex develops models for generating and testing scientific hypotheses. InfiMaker builds desktop five-axis CNC machines, while Anew develops AI-assisted medicines. The investor identity remains separate from former India-focused IDG Ventures and named funds.
- Rounds participated in
- 2
- Confirmed lead rounds
- 2 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $290M 1 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionApex Intelligence
Apex Intelligence is developing self-evolving foundation models to help researchers generate and test scientific hypotheses.
UndisclosedAngel
Lead